文献速递急性肾损伤

尿液沉渣中高SARS-CoV-2病毒载量与急性肾损伤及COVID-19不良预后相关

High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome.
PubMed 文献 · J Am Soc Nephrol · 2021-06-04

该研究对52例PCR确诊的COVID-19住院患者进行尿液沉渣SARS-CoV-2病毒载量qRT-PCR定量,发现39%患者可检出病毒载量,其中85%发生AKI,且AKI患者平均病毒载量高出4倍,AKI诊断后2周内病毒载量最高(7.7倍),较高病毒载量与死亡率相关。肾活检和尿沉渣中SARS-CoV-2蛋白与ACE2部分共定位,但尿沉渣中未检出有感染性的病毒。

要点

  • COVID-19患者尿沉渣可检出SARS-CoV-2病毒载量,39%患者阳性。
  • 尿病毒载量较高者AKI发生率和死亡率更高,AKI后2周内病毒载量达峰值。
  • 尿沉渣未检出有感染性病毒,但病毒蛋白与ACE2在肾小管等部位共定位。

核心结论

  • COVID-19患者尿液沉渣中较高的SARS-CoV-2病毒载量与急性肾损伤发生率增加及死亡率升高相关。
  • 结果进一步支持SARS-CoV-2的肾脏趋向性。

研究设计与样本

  • 研究纳入2020年3月15日至6月8日住院的52例PCR确诊COVID-19患者,采用qRT-PCR定量尿液沉渣SARS-CoV-2病毒载量。
  • 对2例COVID-19肾活检标本和尿沉渣进行SARS-CoV-2刺突蛋白和核衣壳蛋白免疫标记,并对32份尿沉渣进行病毒感染性试验。

主要发现

  • 20例(39%)COVID-19患者尿液沉渣可检出SARS-CoV-2病毒载量,其中17例(85%)发生AKI。
  • 发生AKI的COVID-19患者平均尿病毒载量是未发生AKI患者的4倍。
  • AKI诊断后2周内尿病毒载量最高(7.7倍)。
  • 较高的尿病毒载量与死亡率相关,但与蛋白尿或AKI分期无关。
  • SARS-CoV-2蛋白在肾活检标本的肾小管和壁细胞及尿沉渣细胞中与病毒受体ACE2部分共定位,但尿沉渣中未检出有感染性的SARS-CoV-2。

临床怎么用

  • 对COVID-19合并肾损伤患者,尿液SARS-CoV-2病毒检测可能有助于 informing 医疗照护并改善预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: AKI is a complication of coronavirus disease 2019 (COVID-19) that is associated with high mortality. Despite documented kidney tropism of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there are no consistent reports of viral detection in urine or correlation with AKI or COVID-19 severity. Here, we hypothesize that quantification of the viral load of SARS-CoV-2 in urine sediment from patients with COVID-19 correlates with occurrence of AKI and mortality. METHODS: The viral load of SARS-CoV-2 in urine sediments (U-viral load) was quantified by qRT-PCR in 52 patients with PCR-confirmed COVID-19 diagnosis, who were hospitalized between March 15 and June 8, 2020. Immunolabeling of SARS-CoV-2 proteins Spike and Nucleocapsid was performed in two COVID-19 kidney biopsy specimens and urine sediments. Viral infectivity assays were performed from 32 urine sediments. RESULTS: A total of 20 patients with COVID-19 (39%) had detectable SARS-CoV-2 U-viral load, of which 17 (85%) developed AKI with an average U-viral load four-times higher than patients with COVID-19 who did not have AKI. U-viral load was highest (7.7-fold) within 2 weeks after AKI diagnosis. A higher U-viral load correlated with mortality but not with albuminuria or AKI stage. SARS-CoV-2 proteins partially colocalized with the viral receptor ACE2 in kidney biopsy specimens in tubules and parietal cells, and in urine sediment cells. Infective SARS-CoV-2 was not detected in urine sediments. CONCLUSION: Our results further support SARS-CoV-2 kidney tropism. A higher SARS-CoV-2 viral load in urine sediments from patients with COVID-19 correlated with increased incidence of AKI and mortality. Urinary viral detection could inform the medical care of patients with COVID-19 and kidney injury to improve prognosis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Caceres PS, Savickas G, Murray SL, et al. High SARS-CoV-2 Viral Load in Urine Sediment Correlates with Acute Kidney Injury and Poor COVID-19 Outcome. J Am Soc Nephrol. 2021. PMID: 34088853. doi:10.1681/ASN.2021010059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。